Dimensional Fund Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
AVLSA
OAG
VCM
PA
FIS
Dimensional Fund Advisors's DYN Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Dyne Therapeutics (DYN) stake by 870% in Q1 2026, buying an estimated $14.7M and bringing the position to 951,589 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2038.
Dimensional Fund Advisors first reported a position in DYN in Q4 2021 and has held it in 16 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.
- Dimensional Fund Advisors held 951,589 shares of Dyne Therapeutics worth $17.2M as of Q1 2026.
- Dimensional Fund Advisors bought 853,515 Dyne Therapeutics shares in Q1 2026, an estimated $14.7M.
- Dyne Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2038 holding.
- Dimensional Fund Advisors first reported a position in Dyne Therapeutics in Q4 2021 and has held it in 16 quarters since.
- 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.